The table below shows Disc Medicine, Inc.'s cash flow statement by quarter, as reported in the company's quarterly filings. All figures are in US dollars; negative values appear in red.
Line item
Q1 2026
Q1 2025
Q1 2024
Q1 2023
Q1 2022
Q1 2021
Operating cash flow
-$62.24M
-$41.38M
-$33.60M
-$35.47M
-$13.70M
-$15.01M
Capital expenditure
$0.00
$851.00K
$67.00K
$29.00K
$100.00K
-
Investing cash flow
$58.31M
-$272.63M
-$67.00K
-$29.00K
-$100.00K
-
Dividends paid
-
-
-
-
IRON operating cash flow (10-K history)
Disc Medicine, Inc. reported operating cash flow of -$180.39M for fiscal year 2025. That is down 92.1% from -$93.93M in fiscal 2024. Over the 6 fiscal years shown, operating cash flow declined from -$32.71M (FY 2020) to -$180.39M. Figures come from the company's audited annual reports as filed with the SEC.